Regional Nodal Recurrence in Breast Cancer Patients Treated with Conservative Surgery and Radiation Therapy (BCS+RT)
Overview
Affiliations
Purpose: To review regional nodal (RN) management and identify predictors of RN relapse in patients treated with breast conserving surgery and radiation therapy (BCS+RT).
Methods And Materials: Patients with Stage I and II breast cancer (N = 1920) underwent BCS+RT from 1973 to 2003. Patients undergoing RN were treated with a median dose of 46 Gy. Patients undergoing axillary dissection (AXD, N = 1330) were treated to the breast alone if node-negative (N = 984), and to the breast and supraclavicular fossa if node-positive (N = 346). Patients who did not undergo AXD (N = 590) were treated with RT to the supraclavicular fossa and axilla. Sentinel node biopsy (SNB) was performed on 126 patients. SN-negative patients (N = 110) were treated with tangents only. There were 16 SN-positive patients who did not undergo complete AXD and were treated with RT.
Results: As of September 2005, there have been 36 RN relapses for an actuarial nodal control rate (NCR) of 98% at 10 years. There was no difference in NCR between those undergoing AXD (NCR = 97.4%) and those receiving RT without AXD (NCR = 97.9%). In multivariate analysis, young age, non-Caucasian race, and pathologic nodal status correlated with increased risk of nodal relapse. Of the 126 patients undergoing SNB, there was only 1 nodal recurrence. None of the 16 SN-positive patients treated with RT without AXD had nodal failure.
Conclusions: In patients undergoing BCS+RT, both regional nodal irradiation and AXD (including SNB) resulted in equally high rates of regional nodal control. Nodal RT may also be an effective treatment for SN-positive patients.
Ren F, Yang C, Liu J, Feng K, Shang Q, Kang X Transl Cancer Res. 2024; 13(2):935-951.
PMID: 38482409 PMC: 10928607. DOI: 10.21037/tcr-23-1639.
Oligometastatic Breast Cancer: How to Manage It?.
Barberi V, Pietragalla A, Franceschini G, Marazzi F, Paris I, Cognetti F J Pers Med. 2021; 11(6).
PMID: 34207648 PMC: 8227505. DOI: 10.3390/jpm11060532.
Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review.
Matsushita H, Jingu K, Umezawa R, Yamamoto T, Ishikawa Y, Takahashi N Technol Cancer Res Treat. 2018; 17:1533033818803597.
PMID: 30352542 PMC: 6201169. DOI: 10.1177/1533033818803597.
Zhao M, Liu W, Zhang L, Jin Z, Li Z, Liu C Chronic Dis Transl Med. 2017; 3(1):41-50.
PMID: 29063055 PMC: 5627701. DOI: 10.1016/j.cdtm.2017.01.005.
Lu C, Xu H, Chen X, Tong Z, Liu X, Jia Y Curr Oncol. 2013; 20(6):e585-92.
PMID: 24311960 PMC: 3851356. DOI: 10.3747/co.20.1540.